Medipharm Labs Corp
OTC:MEDIF
Relative Value
The Relative Value of one
MEDIF
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.0549 USD,
Medipharm Labs Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
MEDIF Competitors Multiples
Medipharm Labs Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Medipharm Labs Corp
OTC:MEDIF
|
31.6m USD | 0.7 | -3.9 | -2.6 | -2.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
952.4B USD | 14.6 | 46.1 | 31.1 | 33.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.2B USD | 6.3 | 22.1 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.2B CHF | 4.6 | 30.3 | 12.8 | 14.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.7B CHF | 5.6 | 22.4 | 13.8 | 17.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.5B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD | 4.6 | 16.4 | 10.1 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.6B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.8B USD | 2.6 | 17.8 | 7.4 | 9.2 |